The Defense Logistics Agency (DLA) awarded a $14,041.07 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a...
The U.S. Defense Logistics Agency (DLA) awarded a $15,123.75 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Telmisartan-HCTZ 80-25 mg tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) awarded a $1,105.65 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets, and has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,514.88 firm fixed price delivery order to provide Telmisartan-HCTZ 40-12.5 mg tablets for the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a delivery order worth $7,688.41 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $25,396.17, is for the supply of Telmisartan-HCTZ 40-12.5 mg tablet units in 30-count packages. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities from...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,160.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,015,334 units of Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. This delivery order contract has a period of performance through March 20, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp serves as the prime contractor and holds an indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Telmisartan-HCTZ 40-12.5 mg tablets. The delivery order has a potential value of $3,520.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. This delivery order is issued under an indefinite delivery contract (IDC) that...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,088.15 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Telmisartan 80 mg tablets in 30-count packages, with a completion date of February 28, 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen...